148 related articles for article (PubMed ID: 31854219)
21. A prognostic 4-gene expression signature for squamous cell lung carcinoma.
Li J; Wang J; Chen Y; Yang L; Chen S
J Cell Physiol; 2017 Dec; 232(12):3702-3713. PubMed ID: 28160492
[TBL] [Abstract][Full Text] [Related]
22. Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
Geng H; Li S; Guo Y; Yan F; Han Y; Xu M; Cui Y
Cancer Biomark; 2020; 27(4):525-532. PubMed ID: 32083571
[TBL] [Abstract][Full Text] [Related]
23. Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma.
Li P; Zhang L; Yu X; Tong R; Di X; Mao Y; Gao Y; Zhang K; Feng L; Cheng S
Cancer Sci; 2018 Feb; 109(2):308-316. PubMed ID: 29168602
[TBL] [Abstract][Full Text] [Related]
24. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
Martínez-Terroba E; Behrens C; Agorreta J; Monsó E; Millares L; Felip E; Rosell R; Ramirez JL; Remirez A; Torre W; Gil-Bazo I; Idoate MA; de-Torres JP; Pio R; Wistuba II; Pajares MJ; Montuenga LM
Thorax; 2019 Apr; 74(4):371-379. PubMed ID: 30472670
[TBL] [Abstract][Full Text] [Related]
25. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
[TBL] [Abstract][Full Text] [Related]
26. Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer.
Arroyo M; Larrosa R; Gómez-Maldonado J; Cobo MÁ; Claros MG; Bautista R
Clin Transl Oncol; 2020 Oct; 22(10):1867-1874. PubMed ID: 32180209
[TBL] [Abstract][Full Text] [Related]
27. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
28. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
[TBL] [Abstract][Full Text] [Related]
29. Establishment and validation of an immune-associated signature in lung adenocarcinoma.
Wang Z; Chen X
Int Immunopharmacol; 2020 Nov; 88():106867. PubMed ID: 32799112
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ
Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294
[TBL] [Abstract][Full Text] [Related]
31. Eight-gene signature predicts recurrence in lung adenocarcinoma.
Zhang Y; Fan Q; Guo Y; Zhu K
Cancer Biomark; 2020; 28(4):447-457. PubMed ID: 32508318
[TBL] [Abstract][Full Text] [Related]
32. Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles.
Wang L; Pei Y; Li S; Zhang S; Yang Y
J Comput Biol; 2019 Oct; 26(10):1140-1155. PubMed ID: 31305128
[No Abstract] [Full Text] [Related]
33. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
Wang C; Tan S; Liu WR; Lei Q; Qiao W; Wu Y; Liu X; Cheng W; Wei YQ; Peng Y; Li W
Mol Cancer; 2019 Sep; 18(1):134. PubMed ID: 31484581
[TBL] [Abstract][Full Text] [Related]
34. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
[TBL] [Abstract][Full Text] [Related]
35. Identification of Subtype-Specific Prognostic Genes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients Using an Embedded Feature Selection Algorithm.
Tian S
PLoS One; 2015; 10(7):e0134630. PubMed ID: 26226392
[TBL] [Abstract][Full Text] [Related]
36. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
37. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
[TBL] [Abstract][Full Text] [Related]
39. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
Lu C; Chen H; Shan Z; Yang L
Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
[TBL] [Abstract][Full Text] [Related]
40. Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes.
Pio R; Agorreta J; Montuenga LM
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):986-92.e1-11. PubMed ID: 26162308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
